MEDINET Co., Ltd. Reports Earnings Results for the Third Quarter Ended June 2020
August 07, 2020 at 02:00 am
Share
MEDINET Co., Ltd. reported earnings results for the third quarter ended June 2020. For the period, the company reported Net Sales were ¥637 million compared to ¥755 million a year ago. Operating loss was ¥642 million compared to ¥855 million a year ago. Basic loss per share was ¥4.90 compared to ¥6.83 per share a year ago.
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
MEDINET CO., LTD. 